Literature DB >> 2531074

Evidence from complementation assays in vitro that U5 snRNP is required for both steps of mRNA splicing.

G Winkelmann1, M Bach, R Lührmann.   

Abstract

We have established an in vitro complementation system that has allowed us to investigate the role of individual purified snRNPs in the splicing of pre-mRNA molecules. For the preparation of snRNP-depleted nuclear extracts we have first removed the majority of endogenous snRNPs from the nuclear extracts by one passage over an anti-m3G column and then degraded the remaining snRNPs with micrococcal nuclease. The mixture of snRNPs U1, U2, U4/U6 and U5, obtained by anti-m3G immuno-affinity chromatography, was functionally active and able to restore the splicing of snRNP-depleted nuclear extracts. Mono-Q chromatography was used for further fractionation of the snRNPs U1-U6. This produced three fractions that were highly enriched in snRNPs U1 and U2, U5 and U4/U6 respectively. Conditions were found where addition of the [U1, U2] and the U4/U6 snRNP fractions to the snRNP-depleted nuclear extracts gave rise to the formation of splice intermediates in the absence of any 3' cleavage/exon 1-exon 2 product formation. Only when purified 20S U5 snRNPs were added did both steps of the splicing reaction occur efficiently. Our data suggest that U5 snRNP is absolutely required for the second step of splicing and is needed further for efficient initiation of the splicing reaction. The requirement for U5 snRNPs for splicing was corroborated by glycerol gradient sedimentation analysis of the respective reconstituted pre-mRNP complexes. Stable and efficient formation of 50-60S spliceosomes was observed only in the presence of all snRNPs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531074      PMCID: PMC401390          DOI: 10.1002/j.1460-2075.1989.tb08462.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  44 in total

1.  Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.

Authors:  C R Merril; D Goldman; S A Sedman; M H Ebert
Journal:  Science       Date:  1981-03-27       Impact factor: 47.728

2.  Pre-mRNA splicing by complementation with purified human U1, U2, U4/U6 and U5 snRNPs.

Authors:  A R Krainer
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

3.  Splicing of in vitro synthesized messenger RNA precursors in HeLa cell extracts.

Authors:  N Hernandez; W Keller
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

4.  Splicing of messenger RNA precursors is inhibited by antisera to small nuclear ribonucleoprotein.

Authors:  R A Padgett; S M Mount; J A Steitz; P A Sharp
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

5.  The 5' terminus of the RNA moiety of U1 small nuclear ribonucleoprotein particles is required for the splicing of messenger RNA precursors.

Authors:  A Krämer; W Keller; B Appel; R Lührmann
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

6.  Messenger RNA splicing in vitro: an excised intervening sequence and a potential intermediate.

Authors:  P J Grabowski; R A Padgett; P A Sharp
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

7.  Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro.

Authors:  A R Krainer; T Maniatis; B Ruskin; M R Green
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

8.  Human beta-globin pre-mRNA synthesized in vitro is accurately spliced in Xenopus oocyte nuclei.

Authors:  M R Green; T Maniatis; D A Melton
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

9.  Evidence for the existence of snRNAs U4 and U6 in a single ribonucleoprotein complex and for their association by intermolecular base pairing.

Authors:  P Bringmann; B Appel; J Rinke; R Reuter; H Theissen; R Lührmann
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

10.  Purification of snRNPs U1, U2, U4, U5 and U6 with 2,2,7-trimethylguanosine-specific antibody and definition of their constituent proteins reacting with anti-Sm and anti-(U1)RNP antisera.

Authors:  P Bringmann; J Rinke; B Appel; R Reuter; R Lührmann
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  14 in total

1.  Antisense oligonucleotide binding to U5 snRNP induces a conformational change that exposes the conserved loop of U5 snRNA.

Authors:  G Ast; A M Weiner
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

2.  Antisense probes containing 2-aminoadenosine allow efficient depletion of U5 snRNP from HeLa splicing extracts.

Authors:  G M Lamm; B J Blencowe; B S Sproat; A M Iribarren; U Ryder; A I Lamond
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

Review 3.  Functions of U-snRNPs.

Authors:  R Lührmann
Journal:  Mol Biol Rep       Date:  1990       Impact factor: 2.316

4.  Functional analysis of the U5 snRNA loop 1 in the second catalytic step of yeast pre-mRNA splicing.

Authors:  R T O'Keefe; A J Newman
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

5.  Evidence that U5 snRNP recognizes the 3' splice site for catalytic step II in mammals.

Authors:  M D Chiara; L Palandjian; R Feld Kramer; R Reed
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

6.  Electron microscopy of small nuclear ribonucleoprotein (snRNP) particles U2 and U5: evidence for a common structure-determining principle in the major U snRNP family.

Authors:  B Kastner; M Bach; R Lührmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

7.  Evidence that the 60-kDa protein of 17S U2 small nuclear ribonucleoprotein is immunologically and functionally related to the yeast PRP9 splicing factor and is required for the efficient formation of prespliceosomes.

Authors:  S E Behrens; F Galisson; P Legrain; R Lührmann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Synthetic lethal mutations suggest interactions between U5 small nuclear RNA and four proteins required for the second step of splicing.

Authors:  D Frank; B Patterson; C Guthrie
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

9.  A U5 small nuclear ribonucleoprotein particle protein involved only in the second step of pre-mRNA splicing in Saccharomyces cerevisiae.

Authors:  D S Horowitz; J Abelson
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

10.  Three novel functional variants of human U5 small nuclear RNA.

Authors:  E J Sontheimer; J A Steitz
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.